Nukkleus Stock Fundamentals
| NUKKW Stock | 0.01 0.02 67.44% |
Nukkleus fundamentals help investors to digest information that contributes to Nukkleus' financial success or failures. It also enables traders to predict the movement of Nukkleus Stock. The fundamental analysis module provides a way to measure Nukkleus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nukkleus stock.
At this time, Nukkleus' Selling General Administrative is fairly stable compared to the past year. Total Operating Expenses is likely to climb to about 3.9 M in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 55.8 K in 2024. Nukkleus | Select Account or Indicator |
Nukkleus Company Return On Equity Analysis
Nukkleus' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nukkleus Return On Equity | -0.75 |
Most of Nukkleus' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nukkleus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Nukkleus Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Nukkleus has a Return On Equity of -0.7499. This is 93.77% lower than that of the Software sector and 80.21% lower than that of the Information Technology industry. The return on equity for all United States stocks is 141.9% higher than that of the company.
Nukkleus Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nukkleus's current stock value. Our valuation model uses many indicators to compare Nukkleus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nukkleus competition to find correlations between indicators driving Nukkleus's intrinsic value. More Info.Nukkleus is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . At this time, Nukkleus' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Nukkleus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Nukkleus Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nukkleus' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nukkleus could also be used in its relative valuation, which is a method of valuing Nukkleus by comparing valuation metrics of similar companies.Nukkleus is currently under evaluation in return on equity category among its peers.
Nukkleus Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nukkleus from analyzing Nukkleus' financial statements. These drivers represent accounts that assess Nukkleus' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nukkleus' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 352.3M | 353.2M | 590.2M | 669.0M | 602.1M | 632.2M | |
| Enterprise Value | 357.2M | 352.5M | 353.4M | 593.5M | 534.1M | 273.9M |
Nukkleus Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -1.15 | ||||
| Profit Margin | (2.53) % | ||||
| Operating Margin | (7.94) % | ||||
| Current Valuation | 330.32 M | ||||
| Number Of Shares Shorted | 11.57 K | ||||
| Price To Sales | 10.01 X | ||||
| Revenue | 16.22 M | ||||
| EBITDA | (1.49 M) | ||||
| Net Income | (11.85 M) | ||||
| Total Debt | 3.65 M | ||||
| Book Value Per Share | (6.61) X | ||||
| Cash Flow From Operations | 1.62 M | ||||
| Earnings Per Share | (0.02) X | ||||
| Number Of Employees | 12 | ||||
| Beta | -0.32 | ||||
| Market Capitalization | 107.59 M | ||||
| Total Asset | 18.36 M | ||||
| Retained Earnings | (14.34 M) | ||||
| Working Capital | (3.79 M) | ||||
| Net Asset | 18.36 M |
About Nukkleus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nukkleus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nukkleus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nukkleus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 233.7 K | 167 K | |
| Total Revenue | 18.7 M | 13.7 M | |
| Cost Of Revenue | 18.7 M | 13.6 M | |
| Sales General And Administrative To Revenue | 0.20 | 0.19 | |
| Revenue Per Share | 1.45 | 1.52 | |
| Stock Based Compensation To Revenue | 0.10 | 0.10 | |
| Ebit Per Revenue | (0.18) | (0.19) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nukkleus Stock Analysis
When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.